Clozapine also reduces the risk of recurrent suicidal behavior and is Food and Drug Administration approved for use in patients with schizophrenia and schizoaffective disorder at risk for suicidal behavior.
Up to one third of all patients with a diagnosis of schizophrenia have been shown to be resistant to antipsychotic pharmacotherapy.
Prescription trends for clozapine use have been studied across various geographic locations. Studies indicate that clozapine has been consistently underused in the United States, United Kingdom, Canada, Australia, and New Zealand
- Love me the Clozapine
- Hate it with a passion
- I’ve heard good things but never tried it
- We need more space threads